First therapy targeting Parkinson's proteins enters clinical trials

被引:5
|
作者
Dolgin, Elie
机构
关键词
D O I
10.1038/nm0712-992b
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:992 / 993
页数:2
相关论文
共 50 条
  • [1] First therapy targeting Parkinson's proteins enters clinical trials
    Elie Dolgin
    Nature Medicine, 2012, 18 : 992 - 993
  • [2] First Axl inhibitor enters clinical trials
    Sheridan, Cormac
    NATURE BIOTECHNOLOGY, 2013, 31 (09) : 775 - 776
  • [3] First Axl inhibitor enters clinical trials
    Cormac Sheridan
    Nature Biotechnology, 2013, 31 : 775 - 776
  • [4] First trials test targeting of α-synuclein for Parkinson disease
    Lorraine V. Kalia
    Nature Reviews Neurology, 2022, 18 : 703 - 704
  • [5] First trials test targeting of α-synuclein for Parkinson disease
    Kalia, Lorraine, V
    NATURE REVIEWS NEUROLOGY, 2022, 18 (12) : 703 - 704
  • [7] The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease
    Stephenson, Diane
    Hill, Derek
    Cedarbaum, Jesse M.
    Tome, Maria
    Vamvakas, Spiros
    Romero, Klaus
    Conrado, Daniela J.
    Dexter, David T.
    Seibyl, John
    Jennings, Danna
    Nicholas, Timothy
    Matthews, Dawn
    Xie, Zhiyong
    Imam, Syed
    Maguire, Paul
    Russell, David
    Gordon, Mark Forrest
    Stebbin, Glenn T.
    Somer, Ed
    Gallagher, Jill
    Roach, Arthur
    Basseches, Peter
    Grosset, Donald
    Marek, Kenneth
    JOURNAL OF PARKINSONS DISEASE, 2019, 9 (03) : 553 - 563
  • [9] Gene Therapy for Parkinson's and Alzheimer's Diseases: from the Bench to Clinical Trials
    Nobre, Rui Jorge
    de Almeida, Luis Pereira
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (31) : 3434 - 3445
  • [10] Reporting and methodological quality of clinical trials on exercise therapy for Parkinson's disease
    Silva, Claudia M.
    Travessa, Andre M.
    Bouça-Machado, Raquel
    Caldeira, Daniel
    Ferreira, Joaquim J.
    PARKINSONISM & RELATED DISORDERS, 2019, 69 : 150 - 156